Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus + MMF vs Tacrolimus + MTX for GVHD Prophylaxis
NCT00360685Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Sep 2005
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mycophenolate mofetil in graft-versus-host disease (GVHD), sponsored by Moffitt Cancer Center. Started Sep 2005; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00360685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00360685.